Hard2beat

Inside Hard2beat

Blog about our deals, process etc.

Inside Hard2beat

Blog about our deals, process etc.

Hard2beat

Why we invested in Melanos Care

Melanos Care is a biotech startup redefining skincare with their natural bio-identical melanin from stem cells. It’s a long-lasting solution that blocks sun radiation, the main cause of skin cancer, burns and 80% of visible aging signs, overcoming the limitations of traditional UV creams.

Read More »
Michał Lechowski

Deep Tech January 2026: Dry January? Not for the Engineers.

While the world was busy with New Year’s resolutions and holiday leftovers, European R&D labs were hard at work. In January, investors backed 74 companies tackling “absurdly hard” challenges – from treating brain tumors with electricity to wirelessly powering artificial hearts and manufacturing quantum computers in smartphone factories.

Read More »
Maciej Frankowicz

Why we invested in Ludus AI

Ludus AI is developing a next-generation solution for the 3D game and visualization industry. The company focuses on simplifying the creation of high-quality content in Unreal Engine through the use of artificial intelligence.

Read More »
Konrad Trzyna

Why we invested in Pikralida

Pikralida is developing PKL-021, a rediscovered small-molecule MMP inhibitor that has completed Phase I and is now being advanced into Phase II-ready programs to provide acute neuroprotection after stroke and traumatic brain injury and to offer fast, field-ready treatment for venomous snakebites in humans and pets.

Read More »